Exercise Therapy for People With Sarcopenic Obesity: Myokines and Adipokines as Effective Actors
- PMID: 35250869
- PMCID: PMC8892203
- DOI: 10.3389/fendo.2022.811751
Exercise Therapy for People With Sarcopenic Obesity: Myokines and Adipokines as Effective Actors
Abstract
Sarcopenic obesity is defined as a multifactorial disease in aging with decreased body muscle, decreased muscle strength, decreased independence, increased fat mass, due to decreased physical activity, changes in adipokines and myokines, and decreased satellite cells. People with sarcopenic obesity cause harmful changes in myokines and adipokines. These changes are due to a decrease interleukin-10 (IL-10), interleukin-15 (IL-15), insulin-like growth factor hormone (IGF-1), irisin, leukemia inhibitory factor (LIF), fibroblast growth factor-21 (FGF-21), adiponectin, and apelin. While factors such as myostatin, leptin, interleukin-6 (IL-6), interleukin-8 (IL-8), and resistin increase. The consequences of these changes are an increase in inflammatory factors, increased degradation of muscle proteins, increased fat mass, and decreased muscle tissue, which exacerbates sarcopenia obesity. In contrast, exercise, especially strength training, reverses this process, which includes increasing muscle protein synthesis, increasing myogenesis, increasing mitochondrial biogenesis, increasing brown fat, reducing white fat, reducing inflammatory factors, and reducing muscle atrophy. Since some people with chronic diseases are not able to do high-intensity strength training, exercises with blood flow restriction (BFR) are newly recommended. Numerous studies have shown that low-intensity BFR training produces the same increase in hypertrophy and muscle strength such as high-intensity strength training. Therefore, it seems that exercise interventions with BFR can be an effective way to prevent the exacerbation of sarcopenia obesity. However, due to limited studies on adipokines and exercises with BFR in people with sarcopenic obesity, more research is needed.
Keywords: adipokines; exercise; myokines; obesity; sarcopenia.
Copyright © 2022 Alizadeh Pahlavani.
Conflict of interest statement
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Muscle, Bone, and Fat Crosstalk: the Biological Role of Myokines, Osteokines, and Adipokines.Curr Osteoporos Rep. 2020 Aug;18(4):388-400. doi: 10.1007/s11914-020-00599-y. Curr Osteoporos Rep. 2020. PMID: 32529456 Review.
-
Crosstalk between adipokines and myokines in fat browning.Acta Physiol (Oxf). 2017 Feb;219(2):362-381. doi: 10.1111/apha.12686. Epub 2016 Apr 20. Acta Physiol (Oxf). 2017. PMID: 27040995 Review.
-
Myokines and adipokines in sarcopenia: understanding cross-talk between skeletal muscle and adipose tissue and the role of exercise.Curr Opin Pharmacol. 2020 Jun;52:61-66. doi: 10.1016/j.coph.2020.06.003. Epub 2020 Jul 12. Curr Opin Pharmacol. 2020. PMID: 32668398 Review.
-
Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue.Cytokine Growth Factor Rev. 2017 Feb;33:73-82. doi: 10.1016/j.cytogfr.2016.10.003. Epub 2016 Oct 13. Cytokine Growth Factor Rev. 2017. PMID: 27765498 Review.
-
Sarcopenic obesity.Hormones (Athens). 2018 Sep;17(3):321-331. doi: 10.1007/s42000-018-0049-x. Epub 2018 Jul 16. Hormones (Athens). 2018. PMID: 30014320 Review.
Cited by
-
Exercise-induced signaling pathways to counteracting cardiac apoptotic processes.Front Cell Dev Biol. 2022 Aug 11;10:950927. doi: 10.3389/fcell.2022.950927. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36036015 Free PMC article. Review.
-
Immunogenetic Aspects of Sarcopenic Obesity.Genes (Basel). 2024 Feb 5;15(2):206. doi: 10.3390/genes15020206. Genes (Basel). 2024. PMID: 38397196 Free PMC article. Review.
-
Research Progress on the Effect and Mechanism of Exercise Intervention on Sarcopenia Obesity.Clin Interv Aging. 2024 Aug 8;19:1407-1422. doi: 10.2147/CIA.S473083. eCollection 2024. Clin Interv Aging. 2024. PMID: 39139211 Free PMC article. Review.
-
Understanding the development of sarcopenic obesity.Expert Rev Endocrinol Metab. 2023 Sep-Nov;18(6):469-488. doi: 10.1080/17446651.2023.2267672. Epub 2023 Nov 28. Expert Rev Endocrinol Metab. 2023. PMID: 37840295 Free PMC article. Review.
-
The Modulation of Adipokines, Adipomyokines, and Sleep Disorders on Carcinogenesis.J Clin Med. 2023 Apr 2;12(7):2655. doi: 10.3390/jcm12072655. J Clin Med. 2023. PMID: 37048738 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous